Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
11.89
+0.18 (1.54%)
At close: Aug 21, 2026, 4:00 PM EDT
11.74
-0.15 (-1.26%)
After-hours: Aug 21, 2026, 4:28 PM EDT

Kura Oncology Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,0589046771,068847932
Market Cap Growth
69.48%33.48%-36.58%26.07%-9.08%-56.80%
Enterprise Value
563374239633425396
Last Close Price
11.7110.398.7114.3812.4114.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
13.8913.4012.57---
PB Ratio
21.515.191.642.692.021.84
P/TBV Ratio
22.155.191.642.692.021.84
P/FCF Ratio
--5.06---
P/OCF Ratio
--5.04---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
7.495.544.43---
EV/FCF Ratio
--1.78---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.510.120.040.040.030.01
Debt / FCF Ratio
--0.12---
Net Debt / Equity Ratio
-10.21-3.71-1.72-1.02-1.01-1.01
Net Debt / EBITDA Ratio
1.562.143.702.473.053.91
Net Debt / FCF Ratio
4.219.15-5.313.253.834.84
Asset Turnover
0.120.090.09---
Quick Ratio
4.505.819.3112.0518.2423.13
Current Ratio
4.736.069.4612.2618.5623.26
Return on Equity (ROE)
-167.71%-94.82%-42.91%-37.34%-29.31%-23.35%
Return on Assets (ROA)
-31.30%-25.33%-19.97%-22.89%-17.65%-13.89%
Return on Capital Employed (ROCE)
-67.70%-48.90%-28.40%-40.10%-32.40%-25.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-27.66%-30.82%-25.69%-14.29%-16.04%-14.00%
FCF Yield
-10.95%-7.82%19.76%-11.70%-13.07%-11.34%
Buyback Yield / Dilution
-1.16%-1.76%-17.66%-9.31%-0.96%-25.01%
SEC Filings: 10-K · 10-Q